There is a critical need for better collaboration and care between healthcare providers, community leaders, and the public, in order to tackle these issues and reduce cancer through prevention, education, and access.
New markers found in cancer-associated cells could make it easier for doctors to treat breast cancer, results of a new study published in Cancer Cell suggest. These new types of identifiers will help target chemotherapy by allowing doctors to better differentiate between healthy/normal tissue and cells contributing to cancer.
In 2018, we welcomed several internationally renowned physicians to the Department of Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. These men and women are leaders in their respective fields. They have a track record of innovation and their collaborative multidisciplinary team approach allows them to provide the very highest level of patient care. While these surgeons spearhead the newest treatments and techniques, they are also very compassionate communicators.
Breast fibroadenomas (BFA) are benign (non-cancerous) breast tumors that are comprised of glandular and fibrous breast tissue. These lumps can occur alone, in groups, or as a complex of lumps together. Sometimes women feel these in the breast when doing regular self-breast exams, or they may be found during a routine mammogram. Some are small (less than an inch in size), and others are quite large (the size of a lemon or larger).
NYP/Columbia is a national leader in surgical techniques and innovative treatments for all forms of breast cancer offering the most comprehensive multidisciplinary care available for this disease. As of October 2017 Dr. Roshni Rao will direct the Clinical Breast Surgery program. Dr. Lisa Wiechmann recently joined our surgical team working with Drs. Margaret Chen and Bret Taback at the Columbia campus in uptown and midtown Manhattan while Dr. Michelle Azu brings our expertise to NYP/Lawrence Hospital in Bronxville, New York.
Jeffrey A. Ascherman, MD, site chief of the division of Plastic Surgery at NYP/Columbia, is now offering breast cancer patients a new device that allows them to do part of their breast reconstruction at home, and with faster results.